#giasco - Twitter Hashtag

over 1 year ago

https://t.co/Ssg0Tt4qXH It was a pleasure to present our (@Hadassah_MC) study at #GIASCO on Alpha DaRT for pancreatic cancer ! EUS-guided implantation was feasible, safe, and showed 100% local control with no long-term toxicities. Exciting potential for this novel approach!

0

8

3

1

574

Laia Aceituno @laiaaas

over 1 year ago

🔥 ICI is a safe option to downstage/bridge to transplantation. We present our results at #GIASCO, a hot topic in HCC, thank you to everyone who stopped by!! Thank you to the @AEEHLiver for the support #award More to come soon!!

laiaaas's tweet photo. 🔥 ICI is a safe option to downstage/bridge to transplantation.

We present our results at #GIASCO, a hot topic in HCC, thank you to everyone who stopped by!!

Thank you to the @AEEHLiver for the support #award

More to come soon!! https://t.co/O1pTfhdYHL

1

38

5

3

2K

Kriti Dhamija @dhamija_kr

over 1 year ago

Thrilled to have presented two posters on pancreatic cancer at GI-ASCO 2025. Engaging with cutting edge research and connecting with the experts in the field was truly inspiring. Thank you @DulabhK for all your help. #ASCO #PancreaticCancer #GIASCO #GIASCO2025 #GI25 #ahnimres

dhamija_kr's tweet photo. Thrilled to have presented two posters on pancreatic cancer at GI-ASCO 2025. Engaging with cutting edge research and connecting with the experts in the field was truly inspiring. Thank you @DulabhK for all your help.
#ASCO #PancreaticCancer #GIASCO #GIASCO2025 #GI25 #ahnimres https://t.co/GXmjMFKhLs

0

5

1

352

Yianni Kournoutas, MD @IAKournoutas

over 1 year ago

Great time at #GI25 #GIASCO so far! Had a blast presenting our study on 1st line atezo/bev vs. treme/durva in unresectable HCC. Many thanks to my mentors Dr. Tran Nguyen and Dr. Ou for their support and guidance✊ @MayoHemeOnc @MayoMN_IMRES

IAKournoutas's tweet photo. Great time at #GI25 #GIASCO so far! Had a blast presenting our study on 1st line atezo/bev vs. treme/durva in unresectable HCC.

Many thanks to my mentors Dr. Tran Nguyen and Dr. Ou for their support and guidance✊

@MayoHemeOnc @MayoMN_IMRES https://t.co/dLy2LMPNpe

4

36

6

2

3K

Layal Al Mahmasani @Layalmahmasani

over 1 year ago

Thank you @GABOUALFA for your mentorship and unwavering support! Proud to have presented our work today, and excited for what's next. More is yet to come #GIASCO #BTC @MSKCancerCenter @MSK_DeptOfMed @ASCO

Ghassan Abou-Alfa @GABOUALFA

over 1 year ago

Congratulations @Layalmahmasani on superb effort. @MSKCancerCenter @MSK_DeptOfMed proud of your #BiliaryTractCancer and #obesity self initiated, queried, and followed through from start to end effort . Unsurprisingly impressive!

GABOUALFA's tweet photo. Congratulations @Layalmahmasani on superb effort. @MSKCancerCenter @MSK_DeptOfMed proud of your #BiliaryTractCancer and #obesity self initiated, queried, and followed through from start to end effort . Unsurprisingly impressive! https://t.co/rTR89JMlfk

1

34

4

1

5K

0

26

1

0

2K

Fight Colorectal Cancer

@FightCRC

over 1 year ago

📅Mark your calendars! On Feb. 4 at 1 PM EST, Fight CRC’s "Highlights from @ASCO GI Webinar" brings you the latest in #ColorectalCancer research & care. Hear from Dr. Al Benson, Dr. @Carli__King, & research advocate Michael Holtz. #GI25 #GIASCO Register now: https://t.co/wFPgURzH7c

FightCRC's tweet photo. 📅Mark your calendars! On Feb. 4 at 1 PM EST, Fight CRC’s "Highlights from @ASCO GI Webinar" brings you the latest in #ColorectalCancer research & care. Hear from Dr. Al Benson, Dr. @Carli__King, & research advocate Michael Holtz. #GI25 #GIASCO

Register now: https://t.co/wFPgURzH7c

0

6

1

2

334

Cure GI Cancers

@RueschCenter

over 1 year ago

Not to be missed! Join @benweinbergmd for this exciting discussion tonight at #GIASCO.

Benjamin Weinberg, MD, FACP @benweinbergmd

almost 2 years ago

If you are coming to #GI25, come to our CME satellite symposium on molecular profiling in #pancreaticcancer, including how to target rare drivers such as NRG1 fusions! @gotoPER Be sure to register here: https://t.co/FIe2SiTFDX

benweinbergmd's tweet photo. If you are coming to #GI25, come to our CME satellite symposium on molecular profiling in #pancreaticcancer, including how to target rare drivers such as NRG1 fusions! @gotoPER

Be sure to register here: https://t.co/FIe2SiTFDX https://t.co/Ggm6Fsh57S

0

10

2

0

843

0

2

1

0

286

Yianni Kournoutas, MD @IAKournoutas

over 1 year ago

🛫🛬#GIASCO

1

9

0

688

Bibi Maryam @Maryam7835Bibi

over 1 year ago

Excited to attend my first @ASCO event. Please drop by my poster J14 tomorrow 11:30-1:00, I would love to talk about our abstract # 823, a meta-analysis comparing efficacy and safety of netupitant/palonosetron vs aprepitant. #GI25 #GIASCO2025 #GIASCO #ASCO

Maryam7835Bibi's tweet photo. Excited to attend my first @ASCO event. Please drop by my poster J14 tomorrow 11:30-1:00, I would love to talk about our abstract # 823, a meta-analysis comparing efficacy and safety of netupitant/palonosetron vs aprepitant.
#GI25 #GIASCO2025 #GIASCO #ASCO https://t.co/oFR07ljHEa

1

25

1

1K

Ashish Manne @AshishManne

over 1 year ago

Should we dive deeper into epigenetics to better predict treatment outcomes in PDA? Excited to present our work at #GIASCO this week! Our protein-informed panel reveals multiple predictive signatures in the TCGA database. #GI25 ⁦@ASCO⁩ https://t.co/Bfhf1ZD7np

1

4

0

621

Cindy M. Pabon, MD @cmpabon

over 2 years ago

#ASCO2024 #GIASCO stop by Hallway A to see my mentor, Dr. Blum Murphy, present our neoadjuvant approach of combination dual checkpoint inhibition with chemoRT in resectable gastric adenocarcinoma

cmpabon's tweet photo. #ASCO2024 #GIASCO stop by Hallway A to see my mentor, Dr. Blum Murphy, present our neoadjuvant approach of combination dual checkpoint inhibition with chemoRT in resectable gastric adenocarcinoma https://t.co/F6aBMoIIKV

2

13

1

0

781

Sumanta K. Pal, MD, FASCO

@montypal

over 2 years ago

At #ASCO24 - an incredibly impt topic being addressed by @rachnatshroff & colleagues on June 3 at 10:45 am in E450a. Looking across 5y of @ASCO & #GIASCO symposia, they identify significant gaps in M v F abstract presenters & the difference is quite staggering (ASCO 76% vs 24%, ASCO GI 78% vs 22%, p <0.001 for both). Let's band goether & figure out how to address this.

montypal's tweet photo. At #ASCO24 - an incredibly impt topic being addressed by @rachnatshroff & colleagues on June 3 at 10:45 am in E450a. Looking across 5y of @ASCO & #GIASCO symposia, they identify significant gaps in M v F abstract presenters & the difference is quite staggering (ASCO 76% vs 24%, ASCO GI 78% vs 22%, p <0.001 for both). Let's band goether & figure out how to address this.

4

42

19

4

14K

Cindy M. Pabon, MD @cmpabon

over 2 years ago

Exciting results from the SKYSCRAPER-08 trial, presented by Dr. Chih-Lung Hsu. Combination chemo with anti-PD1 and anti-TIGIT agents show improved OS in metastatic esophageal SCC. #GI24 #GIASCO

cmpabon's tweet photo. Exciting results from the SKYSCRAPER-08 trial, presented by Dr. Chih-Lung Hsu. Combination chemo with anti-PD1 and anti-TIGIT agents show improved OS in metastatic esophageal SCC. #GI24 #GIASCO https://t.co/m0gGV68BGC

1

2

1

0

430

Cindy M. Pabon, MD @cmpabon

over 2 years ago

Dr. Hannah Robinson sheds light on the molecular characteristics of SCC CUP with liver mets. Her findings further support the need for pan-KRAS-directed therapies in GI med onc. #GI24 #GIASCO #DukeFam

cmpabon's tweet photo. Dr. Hannah Robinson sheds light on the molecular characteristics of SCC CUP with liver mets. Her findings further support the need for pan-KRAS-directed therapies in GI med onc. #GI24 #GIASCO #DukeFam https://t.co/kM52HNvKgo

1

7

1

0

564

Mairead G McNamara, MB PhD, FASCO @MGMcNamara

over 2 years ago

Well done to all speakers/chairs on International perspectives on screening etc for Gastric cancer #GIASCO highlighting variance in incidence, need for high risk screening, imaging and laparoscopy @ASCO @ShailjaShahMD @waikleung_hk @NateEvansMD

MGMcNamara's tweet photo. Well done to all speakers/chairs on International perspectives on screening etc for Gastric cancer #GIASCO highlighting variance in incidence, need for high risk screening, imaging and laparoscopy @ASCO @ShailjaShahMD @waikleung_hk @NateEvansMD https://t.co/p4PjesH6aX

0

24

3

0

3K

Cindy M. Pabon, MD @cmpabon

over 2 years ago

CHECKMATE 648 biomarker analysis update provided by Dr. Ken Kato at #GI24. Prospective studies needed to further understand the utility of several biomarker subgroups #GIASCO

cmpabon's tweet photo. CHECKMATE 648 biomarker analysis update provided by Dr. Ken Kato at #GI24. Prospective studies needed to further understand the utility of several biomarker subgroups #GIASCO https://t.co/zmc7qFchVp

0

12

5

2

2K

Cindy M. Pabon, MD @cmpabon

over 2 years ago

Dr. Ian Chau updates on CHECKMATE648: Q-twist analysis suggests quality-adjusted survival favored nivo + chemo and nivo/ipi vs chemo and further supports nivo/chemo and nivo/ipi as 1L for advanced ESCC. #GI24 #GIASCO

cmpabon's tweet photo. Dr. Ian Chau updates on CHECKMATE648: Q-twist analysis suggests quality-adjusted survival favored nivo + chemo and nivo/ipi vs chemo and further supports nivo/chemo and nivo/ipi as 1L for advanced ESCC. #GI24 #GIASCO https://t.co/Qh5LNuuB8M

0

11

3

1

1K

Cindy M. Pabon, MD @cmpabon

over 2 years ago

Dr. Hiroya Takeuchi shows that patients who underwent thoracoscopic esophagectomy as opposed to open esophagectomy showed better PFS and less pulmonary sequelae; non-inferior option for esophageal cancers. #GI24 #GIASCO